The Burden of Atypical Hemolytic Uremic Syndrome and The Clinical Characteristics of Patients in Egyptian Hospitals A Multicenter, Observational, Retrospective Cohort Study in Egypt

Trial Identifier: D928BR00001
Sponsor: AstraZeneca
Start Date: October 2025
Primary Completion Date: September 2026
Study Completion Date: September 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Egypt Alexandria, Egypt
Egypt Assiut, Egypt
Egypt Cairo, Egypt
Egypt Mansoura, Egypt
Egypt New Cairo, Egypt
Egypt Tanta, Egypt
Egypt Zagazig, Egypt